Illuminating the path to advanced healthcare, Bioxytran, Inc. ($BIXT) takes a resolute stand with its specialization in Glycovirology. The financial robustness, represented by a market cap of $24.5M+ and 144.3M+ outstanding shares, harmonizes with their unwavering commitment to redefining health solutions.